Unknown

Dataset Information

HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer.


ABSTRACT:

SUBMITTER: Yamaoka T 

PROVIDER: S-EPMC7653124 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature